MBRC-ADRC M. mulatta 20-210 Female age 22.4 years

Section: 1

SVS
19-3441-1C
GFAP
Section: 2

SVS
20-210-3A
pTau-AT8
Section: 3

SVS
20-210-3A
pTau-AT8
Section: 4

SVS
20-210-4A
pTau-AT8
Section: 5

SVS
20-210-4A
pTau-AT8
Section: 6

SVS
20-210-4A
Tau-RD4
Section: 7

SVS
20-210-1C
b-Amyloid 6E10
Section: 8

SVS
20-210-2A
b-Amyloid 6E10
Section: 9

SVS
20-210-3A
b-Amyloid 6E10
Section: 10

SVS
20-210-3A
b-Amyloid 6E10
Section: 11

SVS
20-210-4A
b-Amyloid 6E10
Section: 12

SVS
20-210-6B
b-Amyloid 6E10
Section: 13

SVS
29-210-8B
b-Amyloid 6E10
Section: 14

SVS
20-210-8A
b-Amyloid 6E10
Section: 15

SVS
20-210-5
TH
Section: 16

SVS
20-210-5
SNCA 4D6
Section: 17

SVS
20-210-1C
Synaptophysin
Section: 18

SVS
20-210-8B
Synaptophysin
Section: 19

SVS
20-210-8B
SV2A
Section: 20

SVS
20-210-5
SV2A
Section: 21

SVS
20-210-4A
SV2A
Section: 22

SVS
20-210-2A
SV2A
Section: 23

SVS
20-210-1C
SV2A
Section: 24

SVS
20-210-4A
Iron
Section: 25

SVS
20-210-5
Iron
Section: 26

SVS
20-210-3A
Neurofilament
Section: 27

SVS
20-210-8B
Neurofilament
Section: 28

SVS
20-210-1C
GFAP
Section: 29

SVS
20-210-5
b-Amyloid 6E10
Section: 30

SVS
20-210-2A
GFAP
Section: 31

SVS
20-210-2A
Iba1
Section: 32

SVS
20-210-C
Iba1
Section: 33

SVS
20-210-1C
Synaptophysin
Section: 34

SVS
20-210-3A
Iron
Section: 35

SVS
20-210-1A
H&E
Section: 36

SVS
20-210-1B
H&E
Section: 37

SVS
20-210-1C
H&E
Section: 38

SVS
20-210-2A
H&E
Section: 39

SVS
20-210-2B
H&E
Section: 40

SVS
20-210-3A
H&E